FCRL3 and rheumatoid arthritis: FCRL3 has been associated with the production of cyclic citrullinated peptide autoantibodies in rheumatoid arthritis (RA) (47) and antibodies to thyroid peroxidase in patients suffering from Graves’ disease (33).